How has nanomedical innovation contributed to the COVID-19 vaccine development?

por Figueiró Longo, João Paulo, Muehlmann, Luis Alexandre
Publicado 2021

Nanotechnology-based self-sterilizing surfaces and their potential in combating coronavirus disease 2019

por Prasher, Parteek, Sharma, Mousmee
Publicado 2021

Metabolite reanalysis revealed potential biomarkers for COVID-19: a potential link with immune response

por Chen, Xin, Gu, Mingli, Li, Tengda, Sun, Yi
Publicado 2021

Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission

por Gemcioglu, Emin, Davutoglu, Mehmet, Catalbas, Ramis, Karabuga, Berkan, Kaptan, Enes, Aypak, Adalet, Kalem, Ayse K, Özdemir, Mustafa, Yeşilova, Necati Y, Kalkan, Emra A, Civak, Musa, Kücüksahin, Orhan, Erden, Abdulsamet, Ates, Ihsan
Publicado 2021

Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro

por Vartak, Richa, Patil, Suyash M, Saraswat, Aishwarya, Patki, Manali, Kunda, Nitesh K, Patel, Ketan
Publicado 2021

Nanomedicine for the poor: a lost cause or an idea whose time has yet to come?

por Uskoković, Vuk
Publicado 2021

Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics

por F Nahhas, Alaa, F Nahhas, Alrayan, J Webster, Thomas
Publicado 2021

COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings

por Fuschillo, Salvatore, Ambrosino, Pasquale, Motta, Andrea, Maniscalco, Mauro
Publicado 2021

Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience

por Farid, Eman, Sridharan, Kannan, Alsegai, Ola AM, Khawaja, Safa Al, Mansoor, Eman J, Teraifi, Noor A, Qahtani, Manaf Al, Salman, Jameela Al
Publicado 2021

Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation

por Singh, Priya, Singh, Deepika, Sa, Pratikshya, Mohapatra, Priyanka, Khuntia, Auromira, K Sahoo, Sanjeeb
Publicado 2021

Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy?

por Spinetti, Gaia, Avolio, Elisa, Madeddu, Paolo
Publicado 2021

SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses

por Rice, Andrew P, Kimata, Jason T
Publicado 2021

Natural selection on synonymous mutations in SARS-CoV-2 and the impact on estimating divergence time

por Yu, Yuanyuan, Li, Yan, Dong, Yu, Wang, Xuekun, Li, Chunxiao, Jiang, Wenqing
Publicado 2021

Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series

por Cui, Ran, Zhu, Ying, Wang, Yulan, Chen, Xiao-Hua, Li, Qiang, Dai, Sheng-Ming, Tong, Qiang
Publicado 2021

Impact of rurality on melanoma diagnosis in Utah

por Bowles, Tawnya L, Sweeney, Carol, Snyder, John, Gygi, Jesse, Bott, Brad, Wray, Daniel, Yeatman, Timothy J, Sause, William T
Publicado 2021

Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancer

por Newman, James, Preeshagul, Isabel, Kohn, Nina, Devoe, Craig, Seetharamu, Nagashree
Publicado 2020

Diffuse midline glioma with H3 K27M-mutation in an 83-year-old woman

por Low, Justin Thomas, Wang, Shih-Hsiu, B Peters, Katherine
Publicado 2021

Visual snow syndrome: evolving neuro-optometric considerations in concussion/mild traumatic brain injury

por Ciuffreda, Kenneth J, Han, MH Esther, Tannen, Barry, Rutner, Daniella
Publicado 2021

Current clinical trials and patent update on lung cancer: a retrospective review

por Batra, Harshul, Pawar, Shrikant, Bahl, Dherya
Publicado 2021

Stem cells for the treatment of glioblastoma: a 20-year perspective

por Calinescu, Anda-Alexandra, Kauss, McKenzie C, Sultan, Zain, Al-Holou, Wajd N, O’Shea, Sue K
Publicado 2021